Stay updated on AEB1102 in Arginase I Deficiency Clinical Trial
Sign up to get notified when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.

Latest updates to the AEB1102 in Arginase I Deficiency Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe 403 Forbidden response and NIH transition notice are gone, replaced by a failed-to-fetch error. The study record remains unavailable.SummaryDifference1%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide notice was added announcing NIH website transition updates and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check35 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the page displaying a 403 error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error page with a Home link. This replaces the usual study details with an access-denied notice.SummaryDifference0.5%

Stay in the know with updates to AEB1102 in Arginase I Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.